View Clinical Trial (Medical Research Study)

A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer - NCT00879086-97227(Clinical Trial 283383)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Portland
State:  
OR
Zip Code: 97227
Conditions: Breast Cancer
Purpose: The purpose of this study in patients with advanced breast cancer is to compare the incidence and severity of neuropathy adverse events for the two treatment groups (eribulin versus ixabepilone) using National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE version 3.0) grading.
Study summary:
Criteria: Inclusion criteria: 1. Female subjects with confirmed locally recurrent or metastatic carcinoma of the breast who have received prior taxane therapy and at least one prior cytotoxic chemotherapy regimen for advanced disease. Exclusion criteria: 1. Subjects who have received prior ixabepilone therapy. 2. Subjects with prior participation in an eribulin clinical study, even if not assigned to eribulin treatment. 3. Subjects with pre-existing neuropathy Grade ≥ 2. 4. Subjects with a history of diabetes mellitus Type 1 or 2. 5. Subjects with bilateral mastectomy which included bilateral axillary lymph node dissection. 6. Subjects with missing digits required for vibration assessment. 7. Subjects with any other concurrent diseases or conditions that would be expected to interfere with neuropathy assessments, which may include vitamin deficiency, sequelae of cerebrovascular disease, thyroid insufficiency, lumbar or cervical radiculopathy, or alcoholic or inflammatory neuropathy.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: October 22, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.